Evidence map›Paper›PMID 31271732›Full record

ArticleThe Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

Preservation of cytotoxic granule production in response to mycobacterial antigens by T-lymphocytes from vertically HIV-infected Brazilian youth on effective combined antiretroviral therapy.

Mauro Pedromonico Arrym, Paulo César Martins Alves, Mariana Virginello Castelhano, Taís Nitsch Mazzola, Renata Muller Banzato Pinto de Lemos, Tânia Regina Zaccariotto, Carlos Emilio Levy, Fernando Guimarães, Marcos Tadeu Nolasco da Silva

Open access · goldAbstract read
In one paragraph

Article in The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mauro Pedromonico ArrymState University of Campinas, Faculty of Medical Sciences, Laboratory of Translational Research in Child and Adolescent Health, Center for Investigation in Pediatrics, Campinas, SP, Brazil.
Paulo César Martins AlvesState University of Campinas, Faculty of Medical Sciences, Laboratory of Translational Research in Child and Adolescent Health, Center for Investigation in Pediatrics, Campinas, SP, Brazil.
Mariana Virginello CastelhanoState University of Campinas, Faculty of Medical Sciences, Laboratory of Translational Research in Child and Adolescent Health, Center for Investigation in Pediatrics, Campinas, SP, Brazil.
Taís Nitsch MazzolaState University of Campinas, Center for Molecular Biology and Genetical Engineering, Campinas, SP, Brazil.
Renata Muller Banzato Pinto de LemosState University of Campinas Clinics Hospital, Campinas, SP, Brazil.
Tânia Regina ZaccariottoState University of Campinas Clinics Hospital, Clinical Pathology Laboratory, Campinas, SP, Brazil.
Carlos Emilio LevyState University of Campinas Clinics Hospital, Clinical Pathology Laboratory, Campinas, SP, Brazil.
Fernando GuimarãesState University of Campinas, Center for Integral Attention to Women's Health, SP, Brazil.
Marcos Tadeu Nolasco da SilvaState University of Campinas, Faculty of Medical Sciences, Laboratory of Translational Research in Child and Adolescent Health, Center for Investigation in Pediatrics, Campinas, SP, Brazil. Electronic address: nolasco@fcm.unicamp.br.
Universidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHIV infection harms adaptive cellular immunity mechanisms. Long-term virological control by combined antiretroviral therapy (cART) reduces the risk of mycobacterial infections. Thus, we aimed to study cellular responses to mycobacterial antigens in 20 HIV-infected adolescents with at least one year of virological control (HIV-RNA <40 copies/mL) and 20 healthy adolescents.

methodsWe evaluated CD8 and γδ T-cell degranulation by measurement of CD107a membrane expression after stimulation with lysates from BCG (10 μg/mL) and H37RA Mycobacterium tuberculosis (Mtb, 10 μg/mL). Immune activation and antigen-presenting ability were also assessed by determination of HLA-DR, CD80, and CD86 markers.

resultsTCR γδ T-cell CD107a expression was similar between groups in response to mycobacterial antigens, and lower in the HIV-infected group in response to mitogen. Higher baseline HLA-DR expression and lower mycobacterial-stimulated expression was found within the HIV-infected group.

conclusionsSimilar degranulation in stimulated CD8+ and TCR γδ T-cells from HIV-infected adolescents, when compared to healthy controls suggests long-term immunological preservation with immune reconstitution under successful cART. However, differences in HLA-DR expression may represent ongoing inflammation and lower specific responses in HIV-infected youth. These features may be relevant in the context of the precocity and severity of vertically acquired HIV infection.

Indexed as

AIDS-Related Opportunistic InfectionsAntigen PresentationAntigens, BacterialAnti-HIV AgentsBiomarkersCD8-Positive T-LymphocytesCross-Sectional StudiesFemaleHumansImmunophenotypingInfectious Disease Transmission, VerticalMaleMycobacterium tuberculosisProspective StudiesReceptors, Antigen, T-Cell, alpha-betaTuberculosisAntigens, BacterialAnti-HIV AgentsBiomarkersMycobacterium tuberculosis antigensReceptors, Antigen, T-Cell, alpha-betaBCGCitotoxicityHIV/AidsImmunologicTuberculosisYouth

Identifiers

PMID31271732
PMCPMC9428219
OpenAlexW2954839117

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.